Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $240 | $1,214 | $3,032 | $12,374 |
| % Growth | -80.2% | -60% | -75.5% | – |
| Cost of Goods Sold | $151,452 | $97,520 | $117,615 | $88,789 |
| Gross Profit | -$151,212 | -$96,306 | -$114,583 | -$76,415 |
| % Margin | -63,005% | -7,932.9% | -3,779.1% | -617.5% |
| R&D Expenses | $151,463 | $97,509 | $118,645 | $106,083 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $22,231 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$151,463 | -$75,398 | -$93,681 | -$65,348 |
| Operating Expenses | $22,231 | $22,111 | $24,964 | $40,735 |
| Operating Income | -$173,443 | -$118,417 | -$139,547 | -$117,150 |
| % Margin | -72,267.9% | -9,754.3% | -4,602.5% | -946.7% |
| Other Income/Exp. Net | $10,470 | $7,629 | $18,598 | $12,475 |
| Pre-Tax Income | -$162,973 | -$110,788 | -$120,949 | -$104,675 |
| Tax Expense | $168 | $170 | $16 | -$86 |
| Net Income | -$163,141 | -$110,958 | -$120,965 | -$104,589 |
| % Margin | -67,975.4% | -9,139.9% | -3,989.6% | -845.2% |
| EPS | -1.17 | -0.8 | -0.88 | -0.76 |
| % Growth | -46.2% | 9.1% | -15.8% | – |
| EPS Diluted | -1.17 | -0.8 | -0.88 | -0.76 |
| Weighted Avg Shares Out | 138,930 | 138,447 | 137,469 | 136,809 |
| Weighted Avg Shares Out Dil | 138,930 | 138,447 | 137,469 | 136,809 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,363 | $10,785 | $12,288 | $14,153 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,998 | $2,917 | $2,867 | $2,886 |
| EBITDA | -$159,975 | -$115,672 | -$135,660 | -$100,230 |
| % Margin | -66,656.3% | -9,528.2% | -4,474.3% | -810% |